Biovaxys Technology logo

BIOV - Biovaxys Technology Share Price

C$0.455 0.0  3.4%

Last Trade - 8:59pm

Sector
Healthcare
Size
Micro Cap
Market Cap £17.9m
Enterprise Value £17.5m
Revenue £n/a
Position in Universe 1333rd / 2679
Bullish
Bearish
Unlock BIOV Revenue
Momentum
Relative Strength (%)
1m +16.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -43.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Oct 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 July 2020, BiovaxysTechnology Corp revenues was not reported. Net lossincreased from C$162K to C$354K. Higher net loss reflectsProfessional Fees increase from C$59K to C$129K (expense),Investor relations increase from C$1K to C$12K (expense),Foreign exchange loss increase from C$0K to C$3K (expense).Basic Earnings per Share excluding Extraordinary Itemsdecreased from -C$0.01 to -C$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIOV Revenue Unlock BIOV Revenue

Net Income

BIOV Net Income Unlock BIOV Revenue

Normalised EPS

BIOV Normalised EPS Unlock BIOV Revenue

PE Ratio Range

BIOV PE Ratio Range Unlock BIOV Revenue

Dividend Yield Range

BIOV Dividend Yield Range Unlock BIOV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BIOV EPS Forecasts Unlock BIOV Revenue
Profile Summary

Biovaxys Technology Corp., formerly Lions Bay Mining Corp., is a Canada-based clinical-stage immunotherapeutics company. The Company develops vaccine platforms for SARS-CoV-2 and various cancers.

Directors
Last Annual October 31st, 2019
Last Interim July 31st, 2020
Incorporated April 25, 2018
Public Since November 21, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Canadian Securities Exchange
Shares in Issue 71,203,091
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIOV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIOV
Upcoming Events for BIOV
Frequently Asked Questions for Biovaxys Technology
What is the Biovaxys Technology share price?

As of 8:59pm, shares in Biovaxys Technology are trading at C$0.455, giving the company a market capitalisation of £17.9m. This share price information is delayed by 15 minutes.

How has the Biovaxys Technology share price performed this year?

Shares in Biovaxys Technology are currently trading at C$0.455 and the price has moved by 0.878k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biovaxys Technology price has moved by 0.773k% over the past year.

What are the analyst and broker recommendations for Biovaxys Technology?

There are no analysts currently covering Biovaxys Technology.

When will Biovaxys Technology next release its financial results?

Biovaxys Technology is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-07-31
What is the Biovaxys Technology dividend yield?

Biovaxys Technology does not currently pay a dividend.

Does Biovaxys Technology pay a dividend?

Biovaxys Technology does not currently pay a dividend.

When does Biovaxys Technology next pay dividends?

Biovaxys Technology does not currently pay a dividend.

How do I buy Biovaxys Technology shares?

To buy shares in Biovaxys Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biovaxys Technology?

Shares in Biovaxys Technology are currently trading at C$0.455, giving the company a market capitalisation of £17.9m.

Where are Biovaxys Technology shares listed? Where are Biovaxys Technology shares listed?

Here are the trading details for Biovaxys Technology:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: BIOV
What kind of share is Biovaxys Technology?

Based on an overall assessment of its quality, value and momentum, Biovaxys Technology is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Biovaxys Technology share price forecast 2021?

We were not able to load any forecast data for Biovaxys Technology.

How can I tell whether the Biovaxys Technology share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biovaxys Technology. Over the past six months, the relative strength of its shares against the market has been 39.58%. At the current price of C$0.455, shares in Biovaxys Technology are trading at 85.25% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biovaxys Technology PE Ratio?

We were not able to find PE ratio data for Biovaxys Technology.

Who are the key directors of Biovaxys Technology?

We were unable to find the directors for Biovaxys Technology.

Who are the major shareholders of Biovaxys Technology?

Here are the top five shareholders of Biovaxys Technology based on the size of their shareholding:

Passin (James) Individual Investor
Percentage owned: 17.66% (12.6m shares)
Kovan (Kenneth) Individual Investor
Percentage owned: 8.48% (6.04m shares)
Berd (David) Individual Investor
Percentage owned: 6.6% (4.70m shares)
Poirier (Jeremy) Individual Investor
Percentage owned: 0.66% (470k shares)
Asuncion (Vicente Benjamin) Individual Investor
Percentage owned: 0.49% (345k shares)
Similar to BIOV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.